Who is sponsoring NCT04909580?

NCT04909580 is sponsored by Margaret Lawson.

What drugs are being tested in NCT04909580?

Interventions in NCT04909580: Decision coaching with a patient decision aid.

What condition does NCT04909580 study?

NCT04909580 studies Type 1 Diabetes Mellitus.

Is NCT04909580 still recruiting?

NCT04909580 is currently completed. Last updated 1 June 2021.

Last reviewed 2021-06-01 · How we verify

NCT04909580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decision Coaching for Youth and Parents Considering Insulin Delivery Methods for Type 1 Diabetes

Completed NA Last updated 1 June 2021

What this trial tests

NA trial testing Decision coaching with a patient decision aid in Type 1 Diabetes Mellitus in 45 participants. Completed in 5 December 2015.

Timeline

5 September 2013

Primary endpoint
31 August 2015

5 December 2015

Quick facts

Lead sponsor	Margaret Lawson
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	45
Start date	5 September 2013
Primary completion	31 August 2015
Estimated completion	5 December 2015
Sites	1 location across Canada

Drugs / interventions tested

Decision coaching with a patient decision aid

Conditions studied

Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →

Sponsor

Margaret Lawson

Who can join

Under 18, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A pre-/post-test design. Youth with type 1 diabetes and their parent(s) were referred to the intervention by their diabetes physician. Decision coaching guided youth and their parents in completing a patient decision aid that was pre-populated with evidence on insulin delivery options. Primary outcomes were youth and parent scores on the low literary version of the Decisional Conflict Scale (DCS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

NCT07142252 — Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus · Phase 2 · recruiting
NCT07296276 — Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM · NA · recruiting
NCT07409701 — Gamification Intervertion in Children With Type 1 Diabetes · NA · recruiting
NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
NCT07434154 — Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04909580 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Margaret Lawson
Last refreshed: 1 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing